93 related articles for article (PubMed ID: 1451115)
1. Role of rel family genes in normal and malignant lymphoid cell growth.
Gilmore TD
Cancer Surv; 1992; 15():69-87. PubMed ID: 1451115
[TBL] [Abstract][Full Text] [Related]
2. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of transformation by the v-rel oncogene.
Hannink M; Temin HM
Crit Rev Oncog; 1991; 2(4):293-309. PubMed ID: 1958712
[TBL] [Abstract][Full Text] [Related]
4. Rel/NF-kappa B and I kappa B factors in oncogenesis.
Luque I; Gélinas C
Semin Cancer Biol; 1997 Apr; 8(2):103-11. PubMed ID: 9299588
[TBL] [Abstract][Full Text] [Related]
5. Expression of v-rel in a replication competent virus: transformation and biochemical characterization.
Morrison LE; Boehmelt G; Beug H; Enrietto PJ
Oncogene; 1991 Sep; 6(9):1657-66. PubMed ID: 1656369
[TBL] [Abstract][Full Text] [Related]
6. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
Sif S; Capobianco AJ; Gilmore TD
Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
[TBL] [Abstract][Full Text] [Related]
7. The v-Rel oncoprotein complexes with new Rel- and RelA-related proteins in transformed cells.
Xu X; Gélinas C
Virology; 1995 Mar; 207(2):362-8. PubMed ID: 7886940
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts.
Morrison LE; Boehmelt G; Enrietto PJ
Oncogene; 1992 Jun; 7(6):1137-47. PubMed ID: 1594245
[TBL] [Abstract][Full Text] [Related]
9. The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.
Gélinas C; Temin HM
Oncogene; 1988 Oct; 3(4):349-55. PubMed ID: 2856247
[TBL] [Abstract][Full Text] [Related]
10. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
Mosialos G; Gilmore TD
Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
[TBL] [Abstract][Full Text] [Related]
11. Identification of v-Rel oncogene-induced inhibitor of apoptosis by differential display.
You M; Bose HR
Methods; 1998 Dec; 16(4):373-85. PubMed ID: 10049645
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of v-rel, the oncogene of reticuloendotheliosis virus strain T.
Bhat GV; Temin HM
Oncogene; 1990 May; 5(5):625-34. PubMed ID: 2189101
[TBL] [Abstract][Full Text] [Related]
13. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
[TBL] [Abstract][Full Text] [Related]
14. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel.
Gilmore TD
Oncogene; 1999 Nov; 18(49):6925-37. PubMed ID: 10602467
[TBL] [Abstract][Full Text] [Related]
15. Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway.
Lanoix J; Lacoste J; Pepin N; Rice N; Hiscott J
Oncogene; 1994 Mar; 9(3):841-52. PubMed ID: 8108127
[TBL] [Abstract][Full Text] [Related]
16. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
Gilmore TD; Cormier C; Jean-Jacques J; Gapuzan ME
Oncogene; 2001 Oct; 20(48):7098-103. PubMed ID: 11704834
[TBL] [Abstract][Full Text] [Related]
17. Differences in kappaB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein.
Nehyba J; Hrdlicková R; Bose HR
Oncogene; 1997 Jun; 14(24):2881-97. PubMed ID: 9205096
[TBL] [Abstract][Full Text] [Related]
18. Rel blocks both anti-Fas- and TNF alpha-induced apoptosis and an intact Rel transactivation domain is essential for this effect.
Zong WX; Bash J; Gélinas C
Cell Death Differ; 1998 Nov; 5(11):963-72. PubMed ID: 9846183
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional activity of rel family proteins.
McDonnell PC; Kumar S; Rabson AB; Gélinas C
Oncogene; 1992 Jan; 7(1):163-70. PubMed ID: 1741161
[TBL] [Abstract][Full Text] [Related]
20. v-rel- and c-rel-protein complexes bind to the NF-kappa B site in vitro.
Kochel T; Rice NR
Oncogene; 1992 Mar; 7(3):567-72. PubMed ID: 1549370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
